Recent advances in mast cell-related skin diseases: particular focus on mastocytosis and urticaria

References

• Jarvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch. Dermatol. Res.295, 2–7 (2003).
   PubMed Web of Science ®Google Scholar
• Groneberg DA, Bester C, Grutzkau A et al. Mast cells and vasculature in atopic dermatitis – potential stimulus of neoangiogenesis. Allergy60, 90–97 (2005).
   PubMed Web of Science ®Google Scholar
• Kontou-Fili K. Clinical advantages of dual activity in urticaria. Allergy55(Suppl. 64), 28–33 (2000).
   Google Scholar
• Chaudhari BR, Murphy RF, Agrawal DK. Following the TRAIL to apoptosis. Immunol. Res.35(3), 249–262 (2006).
   Google Scholar
• Wanderer A, Bernstein IL, Goodman DL et al. The diagnosis and management of urticaria: a practice parameter. Ann. Allergy Asthma Immunol.85, 521–544 (2000).
   Google Scholar
• Valent P, Akin C, Escribano L et al. Standards and standardization in mastocytosis. Consensus statements on diagnostics, treatment recommendations and response criteria. >Eur. J. Clin. Invest.37, 435–453 (2007).
   Google Scholar
• Verzijl A, Heide R, Oranje AP, van Schaik RH. C-kit Asp-816-Val mutation analysis in patients with mastocytosis. Dermatology214, 15–20 (2007).
   PubMed Web of Science ®Google Scholar
• Van Gysel D, Oranje AP. Mastocytosis. In: Textbook of Pediatric Dermatology. Harper JI, Oranje AP, Prose N (Eds). Blackwell Science, London, UK 600–609 (2006).
   Google Scholar
• Wilson TM, Metcalfe DD, Robyn J. Treatment of systemic mastocytosis. Immunol. Allergy Clin. N. Am.26, 549–573 (2006).
   Google Scholar
• Oranje AP, Wolkerstorfer A, Waard-van der Spek de FB. Treatment of erythrodermic atopic dermatitis with ‘wet-wrap’ fluticason propionate 0.05% cream: emollient 1:1 dressings. J. Dermatol. Treat.10, 73–74 (1999).
   Web of Science ®Google Scholar
• Heide R, de Waard-van der Spek FB. den Hollander JC, Tank B, Oranje AP. Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis. Dermatology214, 333–335 (2007).
   Google Scholar
• Heide R, Van Gysel D, Tank B, Oranje AP. Mastocytosis in childhood. EADV Proc. Medimond.703–717 (2006).
   Google Scholar
• Oranje AP, Van Gysel D. Mastocytosis. In: European Handbook of Dermatological Treatments. Katsambas A, Lotti T (Eds). 363–367 (1999).
   Google Scholar
• Hennessy B, Giles F, Cortes J et al. Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience. Am. J. Hematol.77(3), 209–214 (2004).
   PubMed Web of Science ®Google Scholar
• Akin C. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn.8, 412–419 (2006).
   PubMed Web of Science ®Google Scholar
• Worobec AS. Treatment of systemic mast cell disorders. Hematol. Oncol. Clin. North Am.14, 659–687 (2000).
   Google Scholar
• Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ et al. Cladribine therapy for systemic mastocytosis. Blood102, 4270–4276 (2003).
   PubMed Web of Science ®Google Scholar
• Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ et al. Imatinib mesylate in the treatment of systemic mastocytosis: a Phase II trial. Cancer107, 345–351 (2006).
   PubMed Web of Science ®Google Scholar
• Kushnir-Sukhov NM, Brittain E, Reynolds JC, Akin C, Metcalfe DD. Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis. Int. Arch. Allergy Immunol.139, 265–270 (2006).
   Google Scholar
• Hennino A, Berard F, Guillot I et al. Pathophysiology of urticaria. Clin. Rev. Allergy Immunol.30, 3–11 (2006).
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Bindslev-Jensen C, Canonica W et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy61, 321–331(2006).
   PubMed Web of Science ®Google Scholar
• Sachkesen C, Sekerel BE, Orhan F et al. The etiology of different forms of urticaria in childhood. Pediatr. Dermatol.21, 102–108 (2004).
   Google Scholar
• Teillac Hamel C. Chronic urticaria in children. Ann. Dermatol. Venereol.130(1 Suppl. 103), 69–72 (2003).
   Google Scholar
• Kaplan AP. Chronic urticaria: pathogenesis and treatment. J. Allergy Clin. Immunol.114, 465–474 (2004).
   PubMed Web of Science ®Google Scholar
• Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J. Am. Acad. Dermatol.46, 645–645 (2002).
   PubMed Web of Science ®Google Scholar
• Powell RJ, Du Toit GL, Siddique N et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin. Exp. Allergy.37, 631–650 (2007).
   PubMed Web of Science ®Google Scholar
• Brunetti L, Francavilla R, Miniello VL et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J. Allergy Clin. Immunol.114, 922–927 (2004).
   PubMed Web of Science ®Google Scholar
• Simons FE; the ETAC Study Group. Population pharmacokinetics of levocetirizine in very young children: the pediatricians’ perspective. Pediatr. Allergy Immunol.16, 97–103 (2005).
   PubMed Web of Science ®Google Scholar
• Picado C. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders. Expert Opin. Pharmacother.7, 1989–2001 (2006).
   PubMed Web of Science ®Google Scholar
• Galli SJ, Lantz CS. Allergy. In: Fundamental Immunology. (4th edition.) Paul WE (Ed.). Lippincott-Raven Press, PA, USA 1127–1174 (1999).
   Google Scholar
• Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology74(2), 121–132 (2007).
   PubMed Web of Science ®Google Scholar